Výsledky vyhledávání

We are your new team member, leading your journey from groundbreaking invention to market-storming product. Incubation We help invention grow! For scientists aiming to commercialize their innovations, i&i Prague offers step-by-step support, including market analysis, initial funding, and early industry feedback. We connect you with experts from science, law, and industry to ensure your project’s success. We are your new team member, leading your journey from groundbreaking invention to market-storming product. Incubation process Unlock the full potential of your scientific discovery. Our team of experts will provide you with the support you need to successfully commercialize your innovation. Our incubation program includes four basic phases: Idea Evaluation, Pre-Incubation, Incubation and Post-Incubation phase. IDEA EVALUATION Content: Project introduction Duration: Individual Result: Yes/No futher discussion The Idea Evaluation lasts a few weeks. It begins with an introductory meeting to assess the project’s fit with our focus. If relevant, a non-disclosure agreement (NDA) is signed, allowing the team to share confidential data. After that, our team internally analyses the technology’s scientific and commercial potential . The result is a clear decision: either approval or rejection for entry into our program. PRE-INCUBATION Content: Mentoring Duration: Individual Result: Incubation decision In the Pre-Incubation phase , we tailor each project individually . During the second phase of our program, we provide mentoring and hold regular update meetings to track progress and refine the project’s potential. The result of the Pre-Incubation phase is the signing of the Incubation term sheet and incubation agreement. INCUBATION Content: Full-speed project development Duration: Up to 36 months Result: Startup establishment The Incubation phase is the third step of our program, lasting up to 36 months . We focus on market analysis , creating a business plan , building a team (including a CEO ), and developing a proof of concept (PoC) or prototype . We also facilitate investor connections and provide financial support for the startup’s establishment . The result is either the incorporation of a new startup or out-licensing . POST-INCUBATION Content: Startup further support Duration: Individual Result: Support until successful exit The Post-Incubation phase provides ongoing support tailored to the startup’s needs for up to 10 years . Our support includes assistance with business developmen t, access to our expert network , and, if approved, optional investment . The result of the last of our incubation program is either a successful company exit or i&i Prague’s exit from the company . Contact us If you are interested in joining our incubation program, let us know. Our incubation program is open for projects from the Czech Republic and Poland. First Name Last Name Email Message Thanks for submitting! Send

We focus on unique ideas that have the potential to succeed on a global scale. We are dedicated to innovations in Drug Discovery, Diagnostics, MedTech and other Life Science fields that originate from academic institutions. Our portfolio We help invention grow! We help turn groundbreaking scientific discoveries into successful startups and spin-offs. By connecting innovation with capital and expertise, we create growth opportunities. Our objective is to identify new inventions in Drug Discovery, Diagnostics, MedTech and other Life Science fields. This is an overview of our current portfolio: Portofolio companies Adalid Science Novel lipid nanoparticles for effective drug delivery Czech Republic Read More Dracen Pharmaceuticals Tumor-Directed Glutamine Antagonist Czech Republic/ USA Read More PerioTrap Curative treatment of periodontitis Germany Read More Sophomer Syntetic polymer for immunoassays Czech Republic Read More CasInvent Pharma Casein Kinase 1 inhibitors for cancer treatment Czech Republic Read More LAM-X Light-activated nanomaterials fighting infections Czech Republic Read More Reecyclium Separation of rare elements from permanent magnets Czech Republic Read More Sulfotools Green peptide synthesis technology Germany Read More Deep MedChem AI-based tools accelerating drug discovery Czech Republic Read More Pep-Therapy Innovative peptides for oncology France Read More Sampling Human Yeast cell based biocomputing Czech Republic/USA Read More Projects in incubation Here you will find a list of projects that are currently included in our incubation programme: Promental Health In vitro diagnostic panel of novel microRNA biomarkers for early diagnosis of Alzheimer’s disease. Poland Read More Nanoflexion Revolutionary nanofiber-based surgical patch designed to prevent anastomotic leakage and postoperative adhesions. Czech Republic Read More CLLEVERT A system for liquid-liquid microseparations, enabling sample preparation for GC and HPLC analysis. Czech Republic Read More FunBRUSH Antifouling polymer coating technology enhancing the performance and durability of chip surfaces. Czech Republic Read More Our exits Our role is to help launch new startups or spin-offs. The moment our role ends, the exit follows. Here is an overview of our exits: Diana Biotechnologies Pharmaceuticals and highly sensitive diagnostics Czech Republic Read More Elphogene Liquid biopsy technology for cancer diagnostics Czech Republic Read More Riocath New technology used in the production of catheters Czech Republic Read More

We’ll show you what’s new with us here, offer you interesting media outlets that relate to our work, and you can find our press releases here. Our news We help invention grow! Welcome to the News section of i&i Prague – your go-to source for the latest updates straight from our incubator! This is where we keep you informed about everything happening at i&i Prague. Stay up to date with how we are driving innovation and turning scientific discoveries into real-world solutions. Whether you're a researcher, investor, or entrepreneur, this is the place to discover what’s new at i&i Prague. Highlights Blog Our "Swiss Journey" Continues: From CometX at the University of Zurich to the Innovation Biotech Day 2025 in Prague Read More Interview From the Labs of Roche and Pfizer Back to the Czech Republic: Jan Berka Helps Biotech Start-ups and Spin-offs Grow Globally Read More Press release i&i Prague, Technical University of Liberec, and the Faculty of Medicine of CU in Pilsen will support the Nanoflexion technology Read More Press release i&i Prague and the Nencki Institute launch collaboration to develop an innovative test for early diagnosis of Alzheimer’s disease Read More Interview "I love the feeling you get when you discover something new," says Kamila Burdová, the new incubation manager at i&i Prague. Read More Interview Jiří Růžička: The Start-up/Spin-off Gives Scientists the Opportunity to Help Shape the Path of Their Discovery Read More Other news Mar 18 2025 i&i Prague, ÚHKT and Medirekt Partner Join Forces to Bring an Innovative Sample Preparation Technology to Market Read More Feb 25 2025 Czech i&i Prague and the Polish Medical Innovation Institute join forces to support cutting-edge scientific innovation in the region Read More Feb 2 2025 CHEmic podcast with Milan Prasil about how to turn a scientific discovery into a successful start-up/spin-off Read More Jan 20 2025 Neuron 2024 Award for Bridging Science and Business Goes to SophoMer, s.r.o., a Startup from i&i Prague's Portfolio Read More Nov 23 2024 David Stíbal: We believe a startup is one of the best paths nowadays to develop interesting technologies beyond the academic level Read More Nov 7 2024 i&i Prague and other Prague.bio members participate in a business mission with Czech president in Switzerland Read More Oct 30 2024 Jiří Moos: From the lab to the market: What biotech commercialization looks like from the perspective of an incubator Read More Oct 21 2024 PANC-CKI Consortium led by CasInvent Pharma Secures €4M Eurostars Grant for Pancreatic Cancer Research Read More Sep 24 2024 The Prague.bio Conference 2024 welcomed approximately 300 participants from all over the world Read More Mar 11 2024 This fall Prague will be the stage for a showcase of cutting-edge biotechnologies featuring prominent figures such as ... Read More Now 30, 2024 CasInvent Pharma raises € 1.6 million from i&i Prague and Other Investors to Support the Development of CK1 Inhibitors for ... Read More Now 30, 2023 IOCB Tech Group Successfully Represents the Czech Republic at the Prestigious Biotech Conference BIO-Europe 2023 Read More Apr 25, 2023 The Prague.bio international conference will bring together the best of science and business in Prague Read More Feb 7, 2023 New startup in our portfolio: Sophomer's technology will make immunoassays faster, easier and cheaper Read More Feb 6, 2023 Czech liquid biopsy startup Elphogene comes under full control of one of the founders Read More Earlier News

< Back Iva Machová Project Manager Iva Machová is a Project manager at i&i Prague. She is responsible for the analysis of project technology. Before joining our company, Iva worked as a postdoc researcher at the Biomedical Center of the Faculty of Medicine in Pilsen. She holds BSc and MSc degrees from UCT Prague, Czech Republic, and she did her Ph.D. at the Institute of organic chemistry and biochemistry, AS CR. Iva spent several months on a postdoctoral fellowship at Ludwig-Maximilians-Universität München. Due to her scientific experience in biochemistry, she is focused on projects in the field of drug discovery and cell therapy.

< Back Simona Šandová Office Manager During her career, Simona has worked as an Office Manager and a Junior Property Manager. She was responsible for training and conference organization, communication with clients and suppliers as well as administrative assistance for the project and property department. She has considerable experience in administration and office management.

< Back Roberto Fernandez Project Manager Roberto Fernandez is a Project manager at i&i Prague. He holds a BSc in Chemistry from the University of Costa Rica and a MSc in Biochemistry and Biotechnology from Autonomous University of Barcelona. Prior to joining our company Roberto completed his Ph.D. in Macromolecular Chemistry at Charles University, Czech Republic. His multicultural and multidisciplinary background built his interest for applied science, technology transfer and the positive changes this brings to society. In his last year of Ph.D., he participated in the management internship program started by i&i Prague, which provided hands-on experience working at a start-up in the portfolio of i&i Prague. Parallel to his work in i&i Prague, Roberto works as a project manager in the MedTech start-up LAM-X a.s. Due to his experience, Roberto prefers to focus on projects in the field of medical devices and drug delivery.

< Back Mikuláš Vargic External Lawyer Mikuláš studied law at Masaryk University Brno and International and European Law at the University of Antwerp. He is an independent attorney with a specialization in technology transfer. Mikuláš joined our team in 2016 and has almost ten years of experience. He previously worked in a major Czech law firm in Brno and at the South Moravian Innovation Center (JIC). He also works for other clients from both the public sector (universities and research institutions) and the private sector (investors, start-up, and spin-off companies). Mikuláš helps i&i Prague with all legal matters and is involved in negotiating transaction documentation with our partners. His knowledge of business, technical and legal matters will help you to tailor the legal framework for your specific needs.

< Back David Stíbal Board of Directors, Vice Director David Stíbal is the Vice Director at i&i Prague. He holds BSc and MSc degrees from UCT Prague, Czech Republic, and a Ph.D. from the University of Neuchâtel in Switzerland. After his doctorate studies, David worked as a PostDoc at the Massachusetts Institute of Technology. Prior to joining our company, David worked in Lach-Ner s.r.o. as a research scientist, developing modular catalytic systems. His international scientific experience has allowed him to develop a detail-oriented approach to projects from various fields, spanning organic and inorganic chemistry, pharmaceutical sciences, bioinorganic chemistry, and biochemistry. At i&i Prague, David has been focusing on biotechnology evaluations, intellectual property rights, and start-up formation. He will therefore be happy to help assess the scientific background of your project, offer advice during the start-up set-up and early management, and assist in the long-term project development all the way to the successful commercialization.

< Back Jiří Moos CEO, Board of Directors Jiří Moos is our Executive Director, having joined i&i Prague from DiaSorin where he was the Marketing Manager. He is also a member of the TACR GAMA Commercialization Board at the Institute of Molecular Genetics in Prague, and an external member of the Supervisory Board at the Institute of Biotechnology AS CR. Between 2008 and 2016, he acted as a Senior Sales Manager for Sigma-Aldrich (since 2015 a part of Merck KgaA), Czech Republic and Slovakia, and as a Coordinator of regional Sigma-Aldrich Applied Business Unit activities, also covering Hungary and Poland. For six years, he worked for Immunotech a.s., a Beckman-Coulter company located in Prague, first as a Product Manager in the Clinical Chemistry team and later as the Life Science Product Specialist team leader. Jiří also has extensive experience as a Scientific Researcher at the Centre of Assisted Reproduction, General Teaching Hospital in Prague, and as a Research Fellow at the Institute of Molecular Genetics, AS CR in Prague. Jiří Moos completed his Master´s degree in Biology and Chemistry at Charles University in Prague. He received a Ph.D. (CSc.) in Biology from the Institute of Molecular Genetics, AS CR in Prague, followed by almost 3 years of postdoctoral fellowship in the field of Biology of Reproduction at the University of Pennsylvania in Philadelphia. Jiří has also completed the Miller Heiman course of Business and Strategic Selling. If you are interested in cooperation, Jiří will probably be the person you will be meeting quite often. Maybe you are already on his radar because he is the one actively searching for new technologies and early-stage opportunities. He has been in the world of science for almost three decades and has made an extensive network of contacts both in Academia and Industry.

< Back Jiří Růžička Project Manager Jiri Ruzicka is a Project manager at i&i Prague. He is responsible for the analysis of projects, mainly from the scientific and technological aspect. Before joining our company Jiri worked as a Research Associate at the Institute of Experimental Medicine (IEM, part of the Czech Academy of Sciences), as well as within the international research center of IEM, University of Cambridge, and University of Leeds, called Neurorecon. He holds BSc. and MSc. Degrees from the Faculty of Science, Charles University. He has done his Ph.D. at IEM, AS CR, and the 2nd Faculty of Medicine of Charles University. During his postdoc as a member of the Neurorecon team he spent several months at Imperial College London and had close collaboration with the University of Cambridge, including several short research stays. He has 14+ years’ experience in the fields of neuroscience and regenerative medicine with a broad focus on brain/spinal cord injuries, neurodegenerative diseases, and aging. He has been dealing with enzymatic, gene, or cell therapies, biomaterial applications, and genetic models of neurodegenerative disorders.

< Back Martin Kovalčík Communications For almost 13 years, Martin worked as a media coordinator for the respected Czech non-profit organization, People in Need, where he was responsible for the media service for a team of 300 people. Also, he has experience working in several editorial offices. He left his most significant mark at the Metro newspaper, where he worked for over 5 years, the last two as the deputy editor-in-chief.

< Back Milan Prášil Chairman, Board of directors Milan has a thorough knowledge of a business as well as an academic environment. Functioning for eight years as a chancellor of the oldest and one of the largest universities in Central Europe, Charles University in Prague, Milan’s special assignment was a technological transfer and commercialization of academic research results. Milan is well acquainted with the entrepreneurial environment since he founded and managed a consulting company focused mainly on the assessment and improvement of clinical healthcare efficiency and the assessment and professional development of managers. Before he entered the world of entrepreneurship, Milan had spent a great deal of his early professional career developing expertise in the pharma industry. He initially worked for the Czech branches of research-oriented pharma producers (Novo Nordisk, Bayer) in various positions in sales and marketing. He later gained international senior management experience working at a multinational biotech company (Genzyme Therapeutics), where he was responsible for the process of company expansion to the regions of Central and Eastern Europe. Milan Prasil graduated from the 1st medical faculty of Charles University in Prague (1995) and got his MBA from the Rochester Institute of Technology and the U.S. Business School in Prague (1996).